Directory Last Updated: 28 March 2024
Return to Directory Special Interests word selected:- OROPHARYNGEAL
* Information available to verified or subscribed users. The first stage in this process is to Register - please click here to Register.
If you have already Registered, please click here to login.
PhraseConsultantTownSpecial Interests
Benign and malignant laryngeal oropharyngeal thyroid and salivary gland disease
*Consultant(s)*
*Towns*Benign and malignant laryngeal oropharyngeal thyroid and salivary gland disease
core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma
*Consultant(s)*
*Towns*Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery
Oral and oropharyngeal cancer
*Consultant(s)*
*Towns*Oral and oropharyngeal cancer, facial trauma, facial skin cancer, salivary gland disease, cosmetic surgery
oral and oropharyngeal oncology
*Consultant(s)*
*Towns*Dentoalveolar surgery, oral medicine, salivary gland disease, oral and oropharyngeal oncology, head and neck skin malignancy, head and neck reconstructive surgery
oropharyngeal cancer
*Consultant(s)*
*Towns*Clinical oncology, soft tissue and bone sarcomas, oropharyngeal cancer, laryngeal/hypopharyngeal cancer, head and neck sarcomas, salivary gland cancers, gastrointestinal stromal tumours (GIST), late radiotherapy toxicity, survivorship - resilience for patients
oropharyngeal cancers
*Consultant(s)*
*Towns*Head and neck surgery, oropharyngeal cancers, laryngeal malignancies, thyroid diseases, swellings
Recurrent oral and oropharyngeal squamous cell carcinoma - OPSCC
*Consultant(s)*
*Towns*Recurrent oral and oropharyngeal squamous cell carcinoma - OPSCC, facial plastic surgery
treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy
*Consultant(s)*
*Towns*Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery
Spacer

Third Party Advertisement

Adverts by Google